Proteomics Euroscicon 2018
Euroscicon Ltd like to take this opportunity to welcome all of you to “11th Edition of International Conference on Proteomics” which is to be held during March 22-23, 2018 at London, UK. Through our theme “Exploring Novel Drug in the Field of Proteomics”, the conference will analyse the recent advancements and new modes that can be enforced to the research to take Proteomics, one step further.
Proteomics Euroscicon 2018 will impact an attractive moment to meet people in the research field and therefore it takes a delight in opening a gate to meet the ability in the field, young researchers and potential speakers. The conference also includes essential topics on: Proteomics in Drug Discovery, Protein Expression and Analysis, Chromatin Proteomics, Protein Microarrays , The Cancer Proteome, Proteomics for Bioinformatics, Neuroproteomics, Proteomics and Cell Signalling, Metabolomics, Transcriptome Sequencing, Phylogenetic Analysis of Protein, Genomic, Proteomic and Metabolomic Data Integration Strategies and Molecular Docking and Structure-Based Drug Design Strategies.
Hence, we welcome you all to be a part of this event to contribute your novel research ideas.
The study of Proteomics is important as it represents the actual functional molecules in the cell. When mutations occurs in DNA, ultimately proteins are affected. . The major goal of proteomics study helps in understanding the function of proteins and their role by advance technology in order to find a novel drug. When pathogens infect, causing disease these proteins play a major role in signalling the presence & ridding us of these invaders. Almost in each and every process that occurs in our cells from the metabolisation of simple sugar to the distribution of cells is dependent on proteins for smooth operation. In general, proteomics seeks to disclose and quantify as many proteins as possible.
Market Analysis Report
The Global Proteomics market is expected to reach the goal upto $ 30.35 billion by 2021 at a Compound Annual Growth Rate (CAGR) of 15.38 %. The introduction of technology-enabled proteomics products is one of the high-impact providing drivers for the proteomics market growth. These products find extensive applications in drug discovery, diagnostic services, and many other research areas. The major drivers will continue to be the biopharmaceutical industries pursuit of blockbuster drugs and the recent technological advances in the studies of genes and proteins. Proteomics has become a powerful tool for treating various diseases such as diabetes, fatty liver, obesity, and deadly cancers. The presence of organizations such as the Human Proteome Organization promotes the development of new techniques, technologies, and training pertaining to the field of proteomics. This is expected to prompt the market growth over the upcoming period.
Importance & Scope:
There are numerous advances in this proteomics innovation, especially in the field of sub-atomic science. New proteomics and genomics advancements and creations could be utilized for ailment particular biomarker revelation and to screen tolerant reaction to the treatment. Proteomics might likewise set up new, atomic order of the malady. Applying genomic and proteomic strategies to body liquids (serum, cerebrospinal liquid, pee, and so on.) and tissue concentrates would put profitable goal diagnostic force in the hands of the clinician however approval of those techniques is an imperative issue. The quick extension of the analytic apparatuses taking into account advancements in proteomic and genomic advances can be essential for the improvement of customized solution.
Why London, UK?
London is the capital city of England and the United Kingdom. It is the most populous city in the United Kingdom with a metropolitan area of over 13 million inhabitants. Standing on the River Thames, London has been a major settlement for two millennia. London has a diverse range of peoples and cultures, and more than 300 languages are spoken within Greater London. London is a leading global city, with strengths in the arts, commerce, education, entertainment, fashion, finance, healthcare, media, professional services, research and development, tourism and transport all contributing to its prominence., London became a Centre for the worldwide youth culture, exemplified by the Swinging London subculture associated with the Kings Road, Chelsea and Carna by Street. London is the seat of the Government of the United Kingdom. The city is split by the River Thames into North and South, with an informal central London area in its interior.
Global Life science Market Share by Country
Why to attend???
Meet Your Target Market with late business covers Proteomics making news which shows the colossal development in business sector esteem for proteomics innovation till 2019. Since proteomics interrelated with omics sciences like Genomics, exactness Medicine, Lipidomics, Fluxomics and Transcriptomics, it would be an awesome open door for organizations managing Analytical instruments valuable in these fields. Likewise numerous up and participating so as to come understudies and scientists can advantage themselves world class International workshops, symposia amid the gathering which will be directed by specialists in the particular fields.
Major Proteomics Related Associations around the Globe:
- European Proteomics Association
- Australasian Proteomics Society
- HUPO - National and Regional Societies
- British Society for Proteome Research
- DAPSOC - Danish Proteomics Society
- Australasian Proteomics Society
- Swedish Proteomics Society
- Human Proteome Organization
- Japan Human Proteome Organisation (Jhupo)
- Iranian Proteomic Society
- Taiwan Proteomic Society (Tps)
- Indiana Proteomics Consortium
- Proteome Society
- Spanish Proteomics Society– (Seprot)
- Netherlands Proteomic Platform (Npp)
- Italian Proteomic Association (Itpa)
- Portugese Proteomic Association (Rede Procura)
- Iranian Proteomic Society
Executives/Managers and Business Delegates, Director of Laboratories, Universities, Industries, Investigators, Post Doctoral Fellows, Research & Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research organizations.
Ascend in the quantity of pharmaceuticals, Clinical trails, toxicological studies, and wellbeing mindfulness for wholesome items, quick development of proteomics information investigation programming and arrangements, and utilization of proteomics as diagnostics device for biomarker screening of ailments is relied upon to impel the development of this business sector.
Glance at Market of Proteomics:
The Global Proteomics business sector to develop at a CAGR of 8.39% over the period 2014-2019. Propels a major target of proteins have turned into a noteworthy pattern for the development of the business sector as the information gave by these instruments are exceedingly exact and widely utilized for information examination.
Increment popular for personalised medications is one of the significant benefactors to the development of the business sector. Personalized drugs are created by hereditary make-up of an individual, and today are broadly utilized for treatment of diabetes and diseases, for example, lung tumor.
Statistics which shows growth in importance of Proteomics:
Proteomics Market Worth of $2,100 Million by 2019: New Report by Markets & Markets
Statistics of Industries Associated with Proteomics:
North America was the business sector pioneer with an offer of ~42% of the worldwide business sector, trailed by Europe with an offer of ~38%. The vicinity of an expansive number of expository hardware producers has contributed altogether toward the North American and European proteomics market. Be that as it may, the Asia-Pacific area speaks to a huge development open door for the proteomics market amid the figure time of 2014 to 2019. The APAC business sector is relied upon to develop at a CAGR of 23% amid the gauge period. The development in this business sector is driven by the developing pharmaceutical and biotechnology commercial ventures.
The significant players in the proteomics market incorporate Thermo Fisher Scientific (U.S.), Metabolon, Inc., Danaher Corporation, Shimadzu Corporation (Japan), Waters Corporation (U.S.), Agilent Technologies, & Bruker Corporation.
Track 1: Proteomics in Drug Discovery
Drug discovery is a lengthy and highly expensive process that uses a variety of tools from diverse fields. To facilitate the process, several biotechnologies, including genomics, proteomics, cellular and organismic methodologies have been developed. The present review aims to provide a basic understanding of proteomics research by discussing the methods used to study large numbers of proteins and by reviewing the application of proteomics methods to identify biomarkers, to identify drug target and to conduct drug’s mode of action and toxicology studies. It is expected that this will lead to important new insights into disease mechanisms and improved drug discovery strategies to produce novel therapeutics.
- Goal of biomarker discovery
- Identification and assignment of candidate target
- Recombinant protein microarray
- Computational drug desig
- Drug toxicity
- Chemical proteomics
Track 2: Protein Expression and Analysis
Protein expression refers to the way in which proteins are synthesized, modified and regulated in living organisms. In protein research, the term can apply to either the object of study or the laboratory techniques required to manufacture proteins. Protein analysis is the bioinformatics study of protein structure, protein interaction and function using database searches, sequence comparisons, structural and functional predictions.
- Protein expression
- Gel-free & based proteomics technique
- Functional proteomics
- Protein biochemistry
- Protein interaction
- Protein identification
- Protein profiling
- Protein characterization
- Protein analysis
- Recombinant proteins
Track 3: Chromatin Proteomics
More than a thousand proteins are thought to contribute to mammalian chromatin and its regulation, but our understanding of the genomic occupancy and function of most of these proteins is limited. We have used a chromatin proteomic profiling approach to produce a catalogue of proteins associated with genomic regions whose chromatin is marked by specific modified histones. A substantial number of the newly identified proteins are associated with human disease. Future chromatin proteomic profiling studies should prove valuable for identifying additional chromatin-associated proteins in a broad spectrum of cell types.
- Chromatin regulators enriched in chip-ms
- Transcription factors and cofactors enriched in chip-ms
- Cell culture
- Chip-ms and chip-seq
Track 4: Protein Microarrays
Protein microarrays, also known as protein chips that provides a versatile platform for characterization of hundreds of thousands of proteins in a highly parallel and high-throughput way. It is an important class of proteomic technologies that are in fast becoming crucial tools in biochemistry and molecular biology. Two major classes of protein microarrays are defined to describe their applications: analytical and functional protein microarrays. Analytical protein microarrays, mostly antibody microarrays, have become one of the most powerful multiplexed detection technologies. Functional protein microarrays are being increasingly applied to many areas of biological discovery, including studies of protein interaction, biochemical activity, and immune responses.
- Analytical protein microarrays
- Functional protein microarrays
- Protein-protein interactions
- Protein-dna interactions
- Proetin-drug interactions
- Identification of kinase substrates on protein chips
- Profiling immune responses
- Detection of antigen-antibody interaction using protein microarrays
Track 5: The Cancer Proteome
Proteomics technologies are used for early detection and diagnosis of cancers for the development of novel therapeutic agents. Identification of biomarker and also the study of protein expression of the cancer are studied through proteomics platforms. These studies have led to the development of discovering new drugs and targeted therapeutics towards the tumour cells. Detection, prognosis, diagnosis and therapy of breast cancer is now possible with the advancements in the field of proteomics along with the use of mass spectrometry. The discovery of the protein patterns has enabled researchers to distinguish the disease and disease free-state associated with breast cancer has been uncovered with the development of proteomics technologies. This discovery leads to personalized therapy for the patients. Proteins expressed or found in the serum, plasma and the tumour cells using the novel methodologies provide a better view of the heterogeneity of the cancers.
- Protein expression of cancer genes
- Genetic alteration
- Somatic mutations
- Missense mutations
- Frameshift mutations
- Germline mutations
- Nonsense mutations
- Splicing mutations
- Tumour biology
Track 6: Proteomics for Bioinformatics
Bioinformatics is an interdisciplinary field that develops methods and software tools for understanding biological data. As an interdisciplinary field of science, bioinformatics combines computer science, statistics, mathematics, and engineering to analyse and interpret biological data.
- Evolutionary bioinformatics
- Structural bioinformatics
- Next generation sequencing
- Web services in bioinformatics
- Programming languages in bioinformatics
- High performance computing in bioinformatics
- Algorithm biology & health informatics
- Applied bioinformatics and public health microbiology
Track 7: Neuroproteomics
Neuroproteomics is the study of the protein complexes and species that make up the nervous system. These proteins interact to make the neurons connect in such a way to create the complication, that nervous system is known for. Neuroproteomics is a complex field that has a long way to go in terms of profiling the entire neuronal proteome. It is a relatively recent field that has many applications in therapy and science. So far, only small subsets of the neuronal proteome have been mapped, and then only when applied to the proteins involved in the synapse. Neuroproteomics is a step in the right direction of identifying bio-markers that can be used to detect diseases.
- Protein separation
- Protein identification
- Drug addiction
- Brain injury
- Nerve growth
- Cellular neuroscience
- Molecular neuroscience
Track 8: Proteomics and Cell Signalling
Most cells in the human body are subject to continuous change. Old or dysfunctional cells are replaced on a regular basis. In addition, each cell is constantly sensing its environment, and can adapt in response to specific cues, if necessary. This is essential to ascertain proper physiological function. All signal transduction processes consist of individual protein-protein interactions, which are assembled into pathways and networks. They are regulated by protein abundance and localization, and modulated by post-translational modifications. Any drug intervention, therefore must alter at least of these features in order for it to be effective.
- Cell signalling in multicellular organisms
- Receptors for cell motility and differentiation
- Signalling pathways
- Intraspecies and interspecies signalling
- Paracrine signalling
- Synaptic signalling
- Autocrine signalling
- Endocrine signalling
- Signalling through cell-cell contact
Track 9: Metabolomics
Metabolomics is a term that describes the measurement and analysis of metabolites, such as sugars and fats, in the cells of organisms at specific times and under specific conditions. Metabolomics allows researchers to measure physiological effects and to monitor for adverse reactions to drugs. Metabolomics is of interest to physicians because it may lead to improvements in the diagnosis and treatments of human diseases.
- Metabolic fingerprinting
- Metabolic Profiling
- Metabolic targeting
- Environmental metabolomics
- Molecular medicine
- Molecular pathology
Track 10: Transcriptome Sequencing
Transcriptome sequencing covers a wide variety of simple mRNA profiling to discovery and analysis of the entire Transcriptome. These, collectively called RNA-Sequence, are extremely popular for next generation sequencing platforms. Since it is a sequencing based techniques, it is well suited for RNA editing and allele specific expression.
- Small rna-seq
- Whole transcriptome sequencing
- Mapping gene and exon boundaries
- Expressed sequences and cdna libraries
- Next-generation sequencing
- Rna purification & transcriptome enrichment
Track 11: Phylogenetic Analysis of Protein
Phylogenetic analysis is the study of evolutionary relationships among molecules, phenotypes, and organisms. In the context of protein sequence data, phylogenetic analysis is one of the milestone of comparative sequence analysis and has many applications in the study of protein evolution and function.
- Data collection
- Inference of homology
- Sequence alignment
- Alignment trimming
- Phylogenetic analysis
- Protein feature sequences
- Phylogenetic tree
Robust interpretation of experimental results computing discreet biological domains remains a significant challenge in the face of complex biochemical regulation processes such as organismal versus tissue versus cellular metabolism, epigenetics, and protein post-translational modification. Integration of analyses carried out across multiple measurement ,is an upcoming approach to help address these challenges. This review focuses on select methods and tools for the integration of metabolomic with genomic and proteomic data using a variety of approaches .
- Pathway or biochemical-ontology-based integration
- Biological-network-based integration
- Empirical correlation analysis
- Data integration
- Data analysis
- Biochemical processes
Pharmaceutical research has successfully incorporated a wealth of molecular modelling methods, within a variety of drug discovery programs, to study complex biological and chemical systems. The integration of computational and experimental strategies has been of great value in the identification and development of novel promising compounds. Broadly used in modern drug design, molecular docking methods explore the ligand conformations adopted within the binding sites of macromolecular targets. This approach also estimates the ligand-receptor binding free energy by evaluating critical phenomena involved in the intermolecular recognition process.
- Molecular modelling
- Drug discovery
- Molecular target
- Molecular interaction
- Virtual screening
- Structure-based drug design
Related Proteomics Conferences | Proteomics Meeting | Proteomics Events:
- 2017 Colorado Protein Stability Conference, June 20-July 17, 2017 Colorado, USA
- 5th International Congress on Analytical Proteomics, July 3-6, 2017 Caparica, Portugal
- Novel Protein Therapeutics July 11-12, 2017 Baltimore, USA
- Proteomics Bioinformatics July 16 -21, 2017 United Kingdom
- The Protein Society's 31st Annual Symposium, July 24 - 27, 2017 Montreal, CA
- Posttranslational Modification Networks Gordon Research Conference August 13-18, 2017 Hong Kong, China
The Bioprocessing Summit, August 21-25, 2017 Boston, US
5th Annual Antibodies against membrane Protein Targets, September 26-27, 2017 Boston, US
- Central and Eastern European Proteomic Conference (CEEPC), September 27-29, 2017 Kosice, Slovakia
- 16th Human Proteome Organization World Congress, September 17- 21, 2017 Dublin, Ireland
- Global Proteomics Conference, October 12-13, 2017 United Arab Emirates
- Global Summit and Expo on Proteomics, November 9-11, 2017 Valencia, Spain
Proteomics Society, India; German Society for Proteomics (DGPF), Germany; Norwegian Proteomics Society, Norway; British Society for Proteome Research (BSPR), UK; Japanese Proteomics Society, Japan; Korean Human Proteome Organization (KHUPO), Biochemical Society, London, UK; European Proteomics Association (EuPA), Europe; Swedish Proteomics Society (SPS), Sweden; Belgian Proteomics Association, Belgium; Danish Proteomics Society (DAPSOC), Denmark; Portuguese Proteomics Association, Portugal; Finnish Proteomics Society, Finland; Austrian Proteomics Association, Austria; Iranian Proteomics Society, Iran; Netherlands Proteomics Centre, Netherland; Swiss Proteomics Society, Switzerland; Turkish Proteomics Association, Turkey; Australasian Proteomics Society, Australia; Canadian Proteomics Organization, Canada; Taiwan Proteomics Society, Taiwan; Human Proteome Organisation, Asia; Czech Proteomic Society, Czech Republic; Spanish Proteomics Society, Spain.